Arsanis Inc. (ASNS) announced Thursday morning that it has discontinued its Phase 2 study of ASN100. The decision was made following an interim analysis by the independent data review committee.
from RTT - Before the Bell https://ift.tt/2yQk2I8
via IFTTT
No comments:
Post a Comment